UTS site search
ithree institute banner

The ithree institute brings together an internationally competitive team focused on addressing key challenges in the understanding and control of infectious diseases in humans and animals. Our innovative science uses a systems biology approach to develop a greater insight into basic biology and its application to the diagnosis, treatment and prevention of infectious diseases.

The ithree institute is led by Professor Liz Harry, an internationally recognised expert in the field of infectious diseases with a track record of driving innovation both within academia and within industry. It consists of research groups led by globally experienced scientists in the fields of microbial and parasitic infectious diseases, and in the application of their basic research to the treatment and prevention of these diseases.   

The ithree institute has active research programs and collaborations in the fields of bacteriology, parasitology and virology.  We are building our reputation by recruiting academics with a passion to work at the forefront of basic and applied research in the field of infection and immunity. 

The core philosophy at the ithree institute is to work in partnership with others to delivery world-class scientific discovery and to drive innovation. We have established relationships with universities, research institutes, medical institutes and industry, both within Australia and internationally.

Featured News
Professor Liz Harry

Liz Harry appointed Director of ithree

Professor Liz Harry – a world leader in the field of bacterial cell division – has been appointed as Director of ithree institute (infection, immunity and innovation) at UTS Science.
Featured video
Colour bacteria seen under microscope

Global antibiotic resistance crisis

Antibiotics discovery revolutionised human health and medicine. We now take these drugs for granted and bacteria are fighting back leading to antibiotic resistance.
Professor Liz Harry – a world leader in the field of bacterial cell division – has been appointed as Director of ithree institute (infection, immunity and innovation) at UTS Science.
It's UN International Day of Women and Girls in Science, so we shine a spotlight on some of the great women scientists here in Australia.
In the race to develop new antibiotics with completely new modes of action that might address the growing threat posed by antimicrobial resistance, Auspherix Limited has raised £6 million in a Series A venture financing.
Imperial Innovations Group has led a £6m Series A funding round in Auspherix Limited, an early-stage anti-infectives company originated in Sydney, Australia, that is establishing operations on the Stevenage Bioscience Catalyst site just outside of London.